Cannabis and Cannabinoid Research,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 27, 2024
Ultra-endurance
exercise
events
result
in
central
fatigue,
impacting
on
mental
alertness
and
decision
making.
Endocannabinoids
are
typically
elevated
during
endurance
have
been
implicated
processes
such
as
learning
memory,
but
their
role
fatigue
has
never
studied.
Brain Sciences,
Journal Year:
2023,
Volume and Issue:
13(9), P. 1305 - 1305
Published: Sept. 11, 2023
Epilepsy
is
a
complex
neurological
disorder
affecting
millions
worldwide,
with
substantial
number
of
patients
facing
drug-resistant
epilepsy.
This
comprehensive
review
explores
innovative
therapies
for
epilepsy
management,
focusing
on
their
principles,
clinical
evidence,
and
potential
applications.
Traditional
antiseizure
medications
(ASMs)
form
the
cornerstone
treatment,
but
limitations
necessitate
alternative
approaches.
The
delves
into
cutting-edge
such
as
responsive
neurostimulation
(RNS),
vagus
nerve
stimulation
(VNS),
deep
brain
(DBS),
highlighting
mechanisms
action
promising
outcomes.
Additionally,
gene
optogenetics
in
research
discussed,
revealing
groundbreaking
findings
that
shed
light
seizure
mechanisms.
Insights
cannabidiol
(CBD)
ketogenic
diet
adjunctive
further
broaden
spectrum
management.
Challenges
achieving
control
traditional
therapies,
including
treatment
resistance
individual
variability,
are
addressed.
importance
staying
updated
emerging
trends
management
emphasized,
along
hope
improved
therapeutic
options.
Future
directions,
combining
AI
applications,
non-invasive
optogenetics,
hold
promise
personalized
effective
treatment.
As
field
advances,
collaboration
among
researchers
natural
synthetic
biochemistry,
clinicians
from
different
streams
various
forms
medicine,
will
drive
progress
toward
better
higher
quality
life
individuals
living
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(8), P. 3720 - 3720
Published: April 15, 2025
Macrophages
play
a
crucial
role
in
maintaining
intestinal
homeostasis
and
can
exhibit
either
pro-inflammatory
M1
or
anti-inflammatory
M2
phenotypes.
The
cannabinoid
receptor
type
2
(CB2)
is
involved
immune
regulation
may
represent
therapeutic
target
inflammatory
bowel
disease
(IBD).
Our
study
investigates
the
phenotype
of
circulating
macrophages
CB2
expression
children
with
IBD,
assessing
stimulation
macrophage
polarization,
iron
metabolism,
barrier
function.
were
isolated
from
17
ulcerative
colitis
(UC),
21
Crohn’s
(CD),
12
healthy
controls
(CTR).
Cells
treated
agonist
(JWH-133)
an
inverse
(AM630).
polarization
assessed
by
Western
blot.
Iron
metabolism
was
evaluated
through
IL-6,
hepcidin
levels,
FPN-1
expression,
concentration.
Inflammation
cytokine
release.
An
vitro
“immunocompetent
gut”
model
used
to
effects
on
reduced
IBD
macrophages.
Compared
controls,
patients
showed
increased
markers
cytokines,
reduction
IL-13.
Altered
observed,
[Fe3+],
release,
DMT1
FPN-1.
restored
induced
improved
could
novel
for
modulating
function,
mucosal
restoration.
Biology,
Journal Year:
2024,
Volume and Issue:
13(2), P. 116 - 116
Published: Feb. 11, 2024
This
study
aims
to
explore
the
complex
role
of
cannabinoid
type
1
receptor
(CB1)
signaling
in
gastrocnemius
muscle,
assessing
physiological
processes
both
CB1+/+
and
CB1−/−
mice.
The
primary
focus
is
enhance
our
understanding
how
CB1
contributes
mitochondrial
homeostasis.
At
tissue
level,
mice
exhibit
a
substantial
miRNA-related
alteration
muscle
fiber
composition,
characterized
by
an
enrichment
oxidative
fibers.
absence
induces
significant
increase
capacity
supported
elevated
in-gel
activity
Complex
I
IV
respiratory
chain.
increased
associated
with
stress
impaired
antioxidant
defense
systems.
Analysis
biogenesis
markers
indicates
enhanced
for
new
mitochondria
production
mice,
possibly
adapting
altered
composition.
Changes
dynamics,
mitophagy
response,
unfolded
protein
response
(UPR)
pathways
reveal
dynamic
interplay
absence.
interconnected
network,
influenced
fusion
UPR
components,
underlines
dual
regulating
quality
control
generation
mitochondria.
These
findings
deepen
comprehension
impact
on
physiology,
stress,
MQC
processes,
highlighting
cellular
adaptability
CB1−/−.
paves
way
further
exploration
intricate
cascades
cross-talk
between
compartments
context
Cannabis and Cannabinoid Research,
Journal Year:
2022,
Volume and Issue:
7(6), P. 745 - 757
Published: Dec. 1, 2022
Background:
Cannabidiol
(CBD),
a
nonintoxicating
constituent
of
the
cannabis
plant,
recently
gained
lot
interest
among
athletes,
since
it
is
no
longer
considered
as
prohibited
substance
by
World
Anti-Doping
Agency.
The
increasing
prevalence
CBD
use
athletes
driven
perceived
improvement
in
muscle
recovery
and
reduction
pain.
However,
compelling
evidence
from
intervention
studies
lacking
precise
mechanisms
through
which
may
improve
remain
unknown.
This
highlights
need
for
more
scientific
an
evidence-based
background.
In
current
review,
state-of-the-art
knowledge
on
effects
skeletal
tissue
summarized
with
special
emphasis
underlying
molecular
targets.
More
specifically,
large
variety
receptor
families
that
are
believed
to
be
involved
CBD's
physiological
discussed.
Furthermore,
vivo
vitro
investigated
actual
metabolism,
inflammation,
regeneration,
anabolism
summarized,
together
functional
supplementation
human
trials.
Overall,
was
effective
increase
expression
metabolic
regulators
obese
mice
(e.g.,
Akt,
glycogen
synthase
kinase-3).
treatment
rodents
reduced
inflammation
following
eccentric
exercise
(i.e.,
nuclear
factor
kappa
B
[NF-κB]),
model
dystrophy
interleukin-6,
tumor
necrosis
alpha)
obesity
COX-2,
NF-κB).
addition,
did
not
affect
or
anabolism,
but
improved
satellite
cell
differentiation
dystrophic
muscle.
humans,
there
some
indications
creatine
kinase)
performance
squat
performance).
doses
were
highly
variable
(between
16.7
150
mg)
methodological
concerns
should
considered.
Conclusion:
has
prospective
become
adequate
supplement
recovery.
this
research
domain
still
its
infancy
future
addressing
response
required
further
elucidate
ergogenic
potential
CBD.
Nutrients,
Journal Year:
2024,
Volume and Issue:
16(8), P. 1130 - 1130
Published: April 11, 2024
Sarcopenia,
a
decline
in
muscle
mass
and
strength,
can
be
triggered
by
aging
or
medications
like
glucocorticoids.
This
study
investigated
cornflower
(Centaurea
cyanus)
water
extract
(CC)
as
potential
protective
agent
against
DEX-induced
wasting
vitro
vivo.
CC
its
isolated
compounds
mitigated
oxidative
stress,
promoted
myofiber
growth,
boosted
ATP
production
C2C12
myotubes.
Mechanistically,
reduced
protein
degradation
markers,
increased
mitochondrial
content,
activated
synthesis
signaling.
Docking
analysis
suggested
cannabinoid
receptors
(CB)
1
2
targets
of
compounds.
Specifically,
graveobioside
A
from
inhibited
CB1
upregulated
CB2,
subsequently
stimulating
suppressing
degradation.
In
vivo,
treatment
attenuated
wasting,
evidenced
enhanced
grip
exercise
performance,
modulation
gene
expression
related
to
differentiation,
turnover,
performance.
Moreover,
enriched
gut
microbial
diversity,
the
abundance
Clostridium
sensu
stricto
positively
correlated
with
mass.
These
findings
suggest
multifaceted
mode
action
for
CC:
(1)
direct
receptor
system
favoring
anabolic
processes
(2)
indirect
health
through
microbiome.
Overall,
presents
promising
therapeutic
strategy
preventing
treating
atrophy.
Cannabis and Cannabinoid Research,
Journal Year:
2023,
Volume and Issue:
8(6), P. 949 - 954
Published: June 6, 2023
The
World
Anti-Doping
Agency
(WADA)
classifies
cannabis,
all
phytocannabinoids,
and
synthetics
as
doping,
except
for
CBD.
For
agency,
a
method
doping
substance
must
meet
two
criteria:
performance
enhancement
(ergogenicity),
health
risk,
or
violation
of
the
spirit
sports.
Cannabis
is
neither
ergogenic
nor
ergolytic
(performance
worsens),
risks
athletes
are
overestimated
after
20
years
research.
significant
problem
remains
in
complex
(and
difficult
interpretation)
definition
sports,
which
transcends
objectives
sports
excellence
injury
prevention)
moral
policing.
This
perspective
presents
an
evidence-based
counterargument
recommending
removal
cannabis
phytocannabinoids
from
WADA
Prohibited
List.
International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(24), P. 15653 - 15653
Published: Dec. 9, 2022
The
endocannabinoid
system
(ECS)
refers
to
a
widespread
signaling
and
its
alteration
is
implicated
in
growing
number
of
human
diseases.
Cannabinoid
receptors
(CBRs)
are
highly
expressed
the
central
nervous
many
peripheral
tissues.
Evidence
suggests
that
CB1Rs
murine
skeletal
muscle
mainly
cell
membrane,
but
subpopulation
present
also
mitochondria.
However,
very
little
known
about
latter
population.
To
date,
connection
between
function
regulation
intracellular
Ca2+
has
not
been
investigated
yet.
Tamoxifen-inducible
muscle-specific
conditional
CB1
knock-down
(skmCB1-KD,
hereafter
referred
as
Cre+/-)
mice
were
used
this
study
for
functional
morphological
analysis.
After
confirming
CB1R
down-regulation
on
mRNA
protein
level,
we
performed
vitro
force
measurements
found
peak
twitch,
tetanus,
fatigue
decreased
significantly
Cre+/-
mice.
Resting
calcium
concentration,
voltage
dependence
transients
well
activity
dependent
mitochondrial
uptake
essentially
unaltered
by
Cnr1
gene
manipulation.
Nevertheless,
striking
differences
ultrastructural
architecture
network
tissue
from
Our
results
suggest
role
maintaining
physiological
morphology.
Targeting
ECS
could
be
potential
tool
certain
diseases,
including
muscular
dystrophies
where
increased
levels
have
already
described.